1,2-dipalmitoylphosphatidylcholine has been researched along with Breast Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Atukorale, PU; Bielecki, PA; Covarrubias, G; Karathanasis, E; Lorkowski, ME; Loutrianakis, G; Moon, TJ; Sims, HM; Umapathy, MP; Wiese, ML | 1 |
| Douroumis, D; Nandi, U; Onyesom, I | 1 |
| Jose, A; Karnam, S; Ninave, KM; Venuganti, VVK | 1 |
| Chen, JH; Jiang, YN; Mo, HY | 1 |
| Alipour, M; Heney, M; Mugabe, C; Omri, A; Suntres, Z; Th'ng, J; Vergidis, D | 1 |
| Chiu, W; Goodwin, JT; Khant, HA; Li, F; Li, KC; Li, Z; O'Neill, BE; Qin, G; Xia, R | 1 |
| Ahmadibeni, Y; Bothun, G; Gupta, A; Mandal, D; Parang, K | 1 |
| Casale, F; Cilurzo, F; Cosco, D; Fresta, M; Paolino, D | 1 |
| Jin, Y; Li, B; Li, Z; Shen, H; Shen, S; Wang, X; Xie, M; Xu, H; Yao, M | 1 |
| Daoud, SS; Fetouh, MI; Giovanella, BC | 1 |
| Cossu, F; Melis, G; Rombi, G | 1 |
11 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Breast Neoplasms
| Article | Year |
|---|---|
Comparison of the uptake of untargeted and targeted immunostimulatory nanoparticles by immune cells in the microenvironment of metastatic breast cancer.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Breast Neoplasms; Cell Line, Tumor; Cyclic GMP; Dendritic Cells; Immunity, Innate; Immunologic Factors; Ligands; Macrophages; Mice, Inbred BALB C; Nanoparticles; Peptides; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; T-Lymphocytes; Tumor Microenvironment | 2022 |
An in vitro evaluation of antitumor activity of sirolimus-encapsulated liposomes in breast cancer cells.
Topics: 1,2-Dipalmitoylphosphatidylcholine; 3T3 Cells; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Female; Humans; Liposomes; Mice; Nanoparticles; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Sirolimus; Time Factors | 2021 |
Temperature-sensitive liposomes for co-delivery of tamoxifen and imatinib for synergistic breast cancer treatment.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Compounding; Drug Liberation; Female; Humans; Imatinib Mesylate; Liposomes; Lysophosphatidylcholines; Nanoparticles; Tamoxifen; Temperature | 2019 |
[Gene transfer system mediated by PEI-cholesterol lipopolymer with lipid microbubbles].
Topics: 1,2-Dipalmitoylphosphatidylcholine; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cholesterol; Contrast Media; DNA; Female; Fluorocarbons; Gene Transfer Techniques; Genetic Vectors; Green Fluorescent Proteins; Humans; Lipids; Lung Neoplasms; Microbubbles; Phosphatidylethanolamines; Plasmids; Polyethylene Glycols; Polyethyleneimine; Transfection | 2010 |
Effectiveness of liposomal paclitaxel against MCF-7 breast cancer cells.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Chemistry, Pharmaceutical; Dimyristoylphosphatidylcholine; Drug Delivery Systems; Female; Humans; Liposomes; Paclitaxel; Particle Size; Phosphatidylglycerols; Solubility | 2010 |
Partially polymerized liposomes: stable against leakage yet capable of instantaneous release for remote controlled drug delivery.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Aniline Compounds; Biological Availability; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cryoelectron Microscopy; Delayed-Action Preparations; Diynes; Doxorubicin; Drug Stability; Endocytosis; Female; Fluoresceins; Glycine; Gold; Humans; Imino Acids; Lasers; Liposomes; Lysophospholipids; Metal Nanoparticles; Organotechnetium Compounds; Particle Size; Phosphatidylcholines; Phosphatidylethanolamines; Polymers; Surface Plasmon Resonance | 2011 |
Hydrophobicity drives the cellular uptake of short cationic peptide ligands.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Breast Neoplasms; Calorimetry, Differential Scanning; Cations; Cell-Penetrating Peptides; Humans; Hydrophobic and Hydrophilic Interactions; Leukemia; Ligands; Liposomes; Microscopy, Electron, Transmission; Permeability; Phosphatidylserines; Protein Binding; Solubility; Temperature; Tumor Cells, Cultured; Water | 2011 |
Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Cholesterol; Colloids; Deoxycytidine; Dose-Response Relationship, Drug; Drug Compounding; Fatty Acids, Monounsaturated; Female; Gemcitabine; Humans; Kinetics; Lipids; Liposomes; Particle Size; Phosphatidylethanolamines; Phosphatidylglycerols; Polyethylene Glycols; Quaternary Ammonium Compounds; Selective Estrogen Receptor Modulators; Solubility; Tamoxifen; Technology, Pharmaceutical | 2012 |
Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2012 |
Antitumor effect of liposome-incorporated camptothecin in human malignant xenografts.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Breast Neoplasms; Camptothecin; Carcinoma; Cholesterol; Drug Carriers; Drug Evaluation, Preclinical; Humans; Liposomes; Melanoma, Experimental; Mice; Mice, Nude; Molecular Structure; Neoplasm Proteins; Neoplasm Transplantation; Phosphatidylinositols; Remission Induction; Skin Neoplasms; Sphingomyelins; Topoisomerase I Inhibitors | 1995 |
mAb-labeled liposomes in breast cancer cell targeting. Therapeutics and diagnostic use of polyspecific artificial carriers.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antibodies, Monoclonal; Brain Neoplasms; Breast Neoplasms; Drug Carriers; Female; Humans; Iodine Radioisotopes; Liposomes; Liver Neoplasms; Neoplasm Metastasis; Phosphatidylethanolamines; Radioimmunodetection; Technetium | 1993 |